Search

Sulfamethazine is often used to treat disease in the swine industry. Sulfamethazine is available as water or feed medication and historically (over the past 40 years) has been associated with residue violations in both the United States and Europe. Despite sulfamethazine's approval for use as a water medication, little research on the pharmacokinetics of the water formulation is available. Therefore, a pilot study was performed to determine the plasma levels of an approved sulfamethazine water medication. Plasma levels in pigs treated with an oral bolus (250 mg/kg), which is equivalent to the total drug consumed within a 24-h period, achieved therapeutic concentrations (50 µg/ml). Noncompartmental-based pharmacokinetic model parameters for clearance, half-life, and volume of distribution were consistent with previously published values in swine. However, the above treatment resulted in exposure of pen mates to sulfamethazine at levels currently above tolerance (0.1 ppm). Using a physiologically based pharmacokinetic model, the treatment dose simulation was compared with observed plasma levels of treated pigs. Flexibility of the physiologically based pharmacokinetic model also allowed simulation of control-pig plasma levels to estimate contamination exposure. A simulated exposure to 0.15 mg/kg twice within approximately 8 h resulted in detectable levels of sulfamethazine in the control pigs. After initial exposure, a much lower dose of 0.059 mg/kg maintained the contamination levels above tolerance for at least 3 days. These results are of concern for producers and veterinarians, because in commercial farms, the entire barn is often treated, and environmental contamination could result in residues of an unknown duration. [ABSTRACT FROM AUTHOR]

Induction of farrowing with prostaglandins is a way of increasing farrowing supervision and to provide adequate care for piglets in the first hours of life. However, some studies observed negative effects associated with induction, including decreased piglet viability, reduced birth weight and decreased colostrum yield. Furthermore, the farrowing response of sows to prostaglandins treatment varies among studies, largely influenced by the induction protocol applied. Thus, a systematic review and meta-analysis was carried out to evaluate the effects of farrowing induction with prostaglandins on stillbirth rate, birth weight, pre-weaning mortality, weaning weight, farrowing duration and colostrum and milk characteristics as well as the farrowing response to prostaglandin treatment. The interval from farrowing induction to onset of farrowing (IFIOF) was 31 h, and a twice application of prostaglandin increased by 37% the proportion of sows farrowing during the next working day. Prostaglandins had no effect on farrowing duration (P > 0.05). Piglet birth weight and weaning weight were only decreased (P < 0.05) when farrowing was induced ≥3 days before the expected farrowing date (based on herd average or in gestational length of the control group). Induction three or two days before the expected farrowing date had no effect on stillbirth rate; conversely, stillbirth rate was reduced by 28% (P < 0.05) when induction was performed one day before the expected farrowing date. Farrowing induction had no influence on pre-weaning mortality. The present study strengthened the observations that farrowing induction with prostaglandins is a valuable tool to reduce gestational length variation and to synchronize farrowing during the working day, allowing better assistance to sows and piglets. To obtain the maximum benefit of farrowing induction, it is recommended that induction should be performed one or two days before the expected farrowing date. • Farrowing induction ≥3 days prior the due date impairs offspring performance. • Farrowing induced ≤2 days before due date does not adversely affect sow or litter performance. • Farrow induction one day prior to the due date reduces stillbirth rate. • Split or double dose of prostaglandins, 6 h apart, increases farrowing synchrony. • Farrowing induction with prostaglandins does not affect duration of farrowing. [ABSTRACT FROM AUTHOR]

Uterotonics are widely used in the pig industry but their effects have not been investigated critically. The objective was to evaluate the effects of oxytocin and carbetocin on farrowing duration, birth interval, farrowing assistance, stillbirth rate, and piglet viability traits by performing a systematic review and a meta-analysis. The search for studies was performed during January 2020 using the PubMed, ISI Web of Science, Science Direct, and Scopus databases. The literature search was conducted using the key words: oxytocin, pig, farrowing, stillbirth, piglet, dose, and carbetocin. Studies which evaluated the effects of oxytocin or carbetocin on farrowing duration, birth interval, stillbirth rate, and farrowing assistance were included in the review. Of 1215 articles, 23 (1.9%) were selected for fulfilling the criteria for inclusion in the present study. A high variety of doses was observed among studies. Oxytocin increased (30%; P < 0.05) the stillborn proportion in the litters compared to control sows. Both oxytocin and carbetocin increased the need of farrowing assistance by 137% (P < 0.01) and 40% (P < 0.05), respectively, compared to control. The use of oxytocin reduced the farrowing duration by 18% and the birth interval by 17%, while carbetocin reduced the same responses by 27 and 23%, respectively (P < 0.01). When used judiciously, uterotonics are a valuable tool to shorten farrowing duration of hyperprolific sows. However, the treatment is not exempt of deleterious effects for piglets and sows. Therefore, the criteria to use these drugs should be based on individual cases and not as part of hormonal protocols for all parturient sows. • Farrowing duration is decreased by oxytocin and carbetocin. • Birth interval is decreased by oxytocin and carbetocin. • Oxytocin increases the stillborn amount. • Oxytocin and carbetocin increases the need of farrowing assistance. • There is no dose standardization in the use of oxytocin or carbetocin. [ABSTRACT FROM AUTHOR]

The feeding of diets with greater energy content than that needed for body maintenance following mating is believed to reduce embryonic survival in pigs. In swine operations, therefore, feed intake is often restricted during the first and second week of pregnancy to reduce embryo mortality. There is thought to be a relationship between feeding diets that result in energy intake that is greater than that needed for body maintenance and embryonic death. This relationship is associated with lesser than typical progesterone (P4) concentrations when feeding diets with greater energy content due to increased hepatic clearance. There is no consensus, however, as to whether feeding should be restricted during early pregnancy to avert this possible detrimental effect. Thus, the aim of this systematic review is to assess the effect in sows and gilts of feeding diets with different energy contents post-mating on embryonic survival, evaluating when possible, the relationship of a greater energy intake and P4 concentrations on embryonic survival. An electronic search was conducted of the PubMed, Science Direct, Scopus, Web of science, and Scielo databases during June 2018. A total of 109 articles were retrieved, and of these, only 16 articles were selected after applying the selection criteria. There was no negative effect of a greater feed intake than that needed for body maintenance after breeding in 75% of the experiments. Results from 35% of the experiments indicated feeding early pregnant sows a diet with greater energy content than that needed for body maintenance resulted in augmented embryonic death. In 66.7% of the experiments, in which there was assessment of P4 concentration, there was no negative effect of feeding after farrowing a diet with greater energy than that needed for body maintenance. In conclusion, it appears that restricted feed intake in early pregnancy is no longer relevant when there are modern prolific dam lines utilized in swine production enterprises because dietary energy of as great as 54 MJ ME/day had no detrimental effect on embryo survival. [ABSTRACT FROM AUTHOR]

Highlights: [•] The passenger domain of DsrA (rNT-DsrA) was tested as a vaccine against chancroid. [•] rNT-DsrA protected against a homologous challenge. [•] High titered DsrA antisera bound the surface of viable Haemophilus ducreyi. [•] Anti-DsrA IgG partially blocked fibrinogen binding by viable bacteria. [•] Protection by the rNT-DsrA vaccine may involve a novel mechanism. [Copyright &y& Elsevier]

Abstract: This study evaluated immune cell populations in pigs following weaning and vaccination for Mycoplasma hyopneumoniae. Piglets (n =24) were weaned (day 0) at 16 (±1) days of age, and randomly assigned to the vaccination group (n =16) or control group (n =8). Complete blood cell counts, flow cytometry and serology were completed for blood samples collected on days 0 (within hours of weaning), 3, 7, 14, 30 and 60. The M. hyopneumoniae S:P ratios (sample optical density: positive control optical density) were negative in the vaccination group until days 30 and 60, when the S:P ratios were 1.3 and 1.0, respectively. Control animals remained serologically negative. The percentage of CD4+ T cells was less (P <0.01) in control pigs than vaccinated pigs at day 3. In contrast, numbers of CD8+ and CD4+CD8+ T cells were greater (P <0.01) in control pigs than in vaccinated pigs at days 3 and 7. After day 7, few differences in immune cell types were evident between the groups. Differences in lymphocyte populations could not be solely attributed to vaccination, due at least in part, to the confounding influence of weaning. It was difficult to distinguish the influence of vaccination from the impact of weaning on peripheral immune cell populations. [Copyright &y& Elsevier]